rs3824697

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_017433.5(MYO3A):​c.1053+12A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.521 in 1,546,196 control chromosomes in the GnomAD database, including 214,688 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 17825 hom., cov: 32)
Exomes 𝑓: 0.53 ( 196863 hom. )

Consequence

MYO3A
NM_017433.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.16

Publications

7 publications found
Variant links:
Genes affected
MYO3A (HGNC:7601): (myosin IIIA) The protein encoded by this gene belongs to the myosin superfamily. Myosins are actin-dependent motor proteins and are categorized into conventional myosins (class II) and unconventional myosins (classes I and III through XV) based on their variable C-terminal cargo-binding domains. Class III myosins, such as this one, have a kinase domain N-terminal to the conserved N-terminal motor domains and are expressed in photoreceptors. The protein encoded by this gene plays an important role in hearing in humans. Three different recessive, loss of function mutations in the encoded protein have been shown to cause nonsyndromic progressive hearing loss. Expression of this gene is highly restricted, with the strongest expression in retina and cochlea. [provided by RefSeq, Jul 2008]
MYO3A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 30
    Inheritance: AR, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal dominant 90
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 10-26067086-A-G is Benign according to our data. Variant chr10-26067086-A-G is described in ClinVar as Benign. ClinVar VariationId is 45794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.55 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO3ANM_017433.5 linkc.1053+12A>G intron_variant Intron 11 of 34 ENST00000642920.2 NP_059129.3 Q8NEV4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO3AENST00000642920.2 linkc.1053+12A>G intron_variant Intron 11 of 34 NM_017433.5 ENSP00000495965.1 Q8NEV4-1
MYO3AENST00000543632.5 linkc.1053+12A>G intron_variant Intron 10 of 16 1 ENSP00000445909.1 F5H0U9
MYO3AENST00000642197.1 linkn.1257+12A>G intron_variant Intron 11 of 26
MYO3AENST00000647478.1 linkn.1053+12A>G intron_variant Intron 10 of 29 ENSP00000493932.1 A0A2R8Y4D5

Frequencies

GnomAD3 genomes
AF:
0.474
AC:
71960
AN:
151702
Hom.:
17820
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.359
Gnomad AMI
AF:
0.428
Gnomad AMR
AF:
0.409
Gnomad ASJ
AF:
0.534
Gnomad EAS
AF:
0.271
Gnomad SAS
AF:
0.494
Gnomad FIN
AF:
0.578
Gnomad MID
AF:
0.608
Gnomad NFE
AF:
0.554
Gnomad OTH
AF:
0.477
GnomAD2 exomes
AF:
0.477
AC:
118721
AN:
248664
AF XY:
0.489
show subpopulations
Gnomad AFR exome
AF:
0.352
Gnomad AMR exome
AF:
0.319
Gnomad ASJ exome
AF:
0.527
Gnomad EAS exome
AF:
0.271
Gnomad FIN exome
AF:
0.578
Gnomad NFE exome
AF:
0.551
Gnomad OTH exome
AF:
0.503
GnomAD4 exome
AF:
0.526
AC:
732951
AN:
1394376
Hom.:
196863
Cov.:
24
AF XY:
0.526
AC XY:
366922
AN XY:
697350
show subpopulations
African (AFR)
AF:
0.357
AC:
11409
AN:
31940
American (AMR)
AF:
0.331
AC:
14706
AN:
44386
Ashkenazi Jewish (ASJ)
AF:
0.521
AC:
13320
AN:
25578
East Asian (EAS)
AF:
0.262
AC:
10263
AN:
39210
South Asian (SAS)
AF:
0.482
AC:
40769
AN:
84574
European-Finnish (FIN)
AF:
0.575
AC:
30487
AN:
53012
Middle Eastern (MID)
AF:
0.557
AC:
3125
AN:
5614
European-Non Finnish (NFE)
AF:
0.550
AC:
578992
AN:
1051906
Other (OTH)
AF:
0.514
AC:
29880
AN:
58156
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
13948
27896
41844
55792
69740
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15658
31316
46974
62632
78290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.474
AC:
71978
AN:
151820
Hom.:
17825
Cov.:
32
AF XY:
0.474
AC XY:
35153
AN XY:
74198
show subpopulations
African (AFR)
AF:
0.359
AC:
14860
AN:
41430
American (AMR)
AF:
0.409
AC:
6238
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.534
AC:
1854
AN:
3472
East Asian (EAS)
AF:
0.271
AC:
1402
AN:
5166
South Asian (SAS)
AF:
0.493
AC:
2378
AN:
4826
European-Finnish (FIN)
AF:
0.578
AC:
6086
AN:
10526
Middle Eastern (MID)
AF:
0.592
AC:
173
AN:
292
European-Non Finnish (NFE)
AF:
0.554
AC:
37597
AN:
67834
Other (OTH)
AF:
0.477
AC:
1003
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1856
3711
5567
7422
9278
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.518
Hom.:
3734
Bravo
AF:
0.451
Asia WGS
AF:
0.398
AC:
1384
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 20, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

1053+12A>G in Intron 11 of MYO3A: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus seq uence and has been identified in 46.6% (3270/7020) of European American chromoso mes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs .washington.edu/EVS; dbSNP rs3824697). -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Jun 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 30 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.89
DANN
Benign
0.44
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3824697; hg19: chr10-26356015; COSMIC: COSV56348765; API